Page last updated: 2024-11-01

nitroglycerin and Anxiety

nitroglycerin has been researched along with Anxiety in 10 studies

Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Research Excerpts

ExcerptRelevanceReference
" The aim of this study was to analyze the sensitivity of rats with prenatal hyperhomocysteinemia (hHCY) in respect of the development of behavioral correlates of headache and spreading cortical depolarization (CSD) in a migraine model induced by the administration of the nitric oxide (NO) donor nitroglycerin."8.12Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats. ( Bogatova, K; Enikeev, D; Gerasimova, E; Giniatullin, R; Hermann, A; Sitdikova, G; Yakovleva, O, 2022)
"Chronic migraine is a debilitating disorder that has a significant impact on patients and society."5.46Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide. ( Alipour, MR; Babri, S; Bughchechi, R; Farajdokht, F; Karimi, P; Mohaddes, G, 2017)
" The aim of this study was to analyze the sensitivity of rats with prenatal hyperhomocysteinemia (hHCY) in respect of the development of behavioral correlates of headache and spreading cortical depolarization (CSD) in a migraine model induced by the administration of the nitric oxide (NO) donor nitroglycerin."4.12Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats. ( Bogatova, K; Enikeev, D; Gerasimova, E; Giniatullin, R; Hermann, A; Sitdikova, G; Yakovleva, O, 2022)
"Systemic administration of nitroglycerin (NTG) consistently provokes spontaneous-like migraine attacks in migraine sufferers, and in rat it induces hyperalgesia and allodynia."3.83Ghrelin attenuates hyperalgesia and light aversion-induced by nitroglycerin in male rats. ( Babri, S; Farajdokht, F; Karimi, P; Mohaddes, G, 2016)
"Pretreatment with PL ameliorated migraine headache behaviors in the NTG-induced migraine rat model, suggesting pretreatment with PL is beneficial for migraine headache treatment."1.51Effect of Paeonia lactiflora, a traditional Chinese herb, on migraines based on clinical application and animal behavior analyses. ( Chen, CH; Hsieh, CL; Li, JM; Liao, CC; Lin, CL, 2019)
"Chronic migraine is a debilitating disorder that has a significant impact on patients and society."1.46Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide. ( Alipour, MR; Babri, S; Bughchechi, R; Farajdokht, F; Karimi, P; Mohaddes, G, 2017)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19905 (50.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Gerasimova, E1
Yakovleva, O1
Enikeev, D1
Bogatova, K1
Hermann, A1
Giniatullin, R1
Sitdikova, G1
Liao, CC1
Li, JM1
Chen, CH1
Lin, CL1
Hsieh, CL1
Farajdokht, F2
Babri, S2
Karimi, P2
Mohaddes, G2
Alipour, MR1
Bughchechi, R1
PAUL, O1
SHAPIRO, S1
Wheatley, D1
Jones, DA1
West, RR1
Piris, P1
Beaughard, M1
Cosnier, D1
Labrid, C1
Goia, F1
Tesi, U1
Carezzana, G1
Schettino, F1
Silvestri, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Enhancing Standard Cardiac Rehabilitation With Stress Management Training in Patients With Heart Disease[NCT00981253]164 participants (Actual)Interventional2009-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Absolute Composite Stress Score

A global stress measure (mean rank), was the primary outcome combining the following components at baseline and following treatment: Beck Depression Inventory II, Spielberger Anxiety Inventory-State, General Health Questionnaire, PROMIS Anger Questionnaire, and Perceived Stress Scale. A range from 1 to 147 was present with higher scores suggestive of better function. The change in each individual scaled score is presented in primary outcome 2. (NCT00981253)
Timeframe: Baseline; 12 weeks

InterventionMean rank score (Least Squares Mean)
SMT-enhanced Cardiac Rehabilitation77.6
Standard Cardiac Rehabilitation67.5

Baroreflex Sensitivity

Baroreflex sensitivity was obtained from beat-to-beat heart rate and blood pressure recorded from patients in the supine position with a Nexfin noninvasive blood pressure monitor. (NCT00981253)
Timeframe: At 12 weeks

Interventionms/mm Hg (Least Squares Mean)
SMT-Enhanced Cardiac Rehabilitation0.47
Standard Cardiac Rehabilitation0.93

Change in High-sensitivity C-Reactive Protein

High-sensitivity C-reactive protein was quantified by ELISA. Values >10 mg/L were truncated at 10 to account for acute inflammatory processes that may have skewed the distribution of this blood marker. (NCT00981253)
Timeframe: Baseline; 12 weeks

Interventionmg/L (Least Squares Mean)
SMT-enhanced Cardiac Rehabilitation-0.9
Standard Cardiac Rehabilitation-0.4

Heart Rate Variability During Controlled Breathing (HRV-DB)

Heart rate variability was obtained from beat-to-beat heart rate. Heart rate was assessed from R-R interval changes elicited during a 100-second controlled breathing task. (NCT00981253)
Timeframe: At 12 weeks

Interventionms (Least Squares Mean)
SMT-Enhanced Cardiac Rehabilitation13.1
Standard Cardiac Rehabilitation26.0

Change From Baseline to 12 Weeks in Individual Scaled Scores

"Beck Depression Inventory II: 21-item scale used to measure depression. Scores range from 0 to 63, with higher scores suggesting greater depressive symptoms.~State-Trait Anxiety Inventory: 20-item scale which assess levels of state anxiety. Scores range from 20 to 80 with scores ≥40 suggesting clinically significant anxiety.~General Health Questionnaire:12-item measure of general distress. Scores range from 0 to 36, with higher scores indicating greater emotional distress.~Patient-Reported Outcomes Measurement Information System (PROMIS) Anger: 8-item scale which assesses anger. Scores range from 8 to 40, with higher scores indicating greater anger.~Perceived Stress Scale: 10-item measure of general distress and perceived ability to cope. Scores range from 0 to 40, higher scores indicate greater stress." (NCT00981253)
Timeframe: Baseline; 12 weeks

,
Interventionunits on a scale (Least Squares Mean)
Beck Depression Inventory-IISpielberger Anxiety Inventory-StateGeneral Health QuestionnairePROMIS Anger QuestionnairePerceived Stress Score
SMT-Enhanced Cardiac Rehabilitation-3.5-5.6-4.8-2.0-4.2
Standard Cardiac Rehabilitation-2.6-2.6-3.3-1.0-2.6

Heart Rate Variability During Rest

Heart rate variability was obtained from beat-to-beat heart rate. Heart rate was assessed from R-R interval changes elicited during 5 minutes of normal relaxed breathing (NCT00981253)
Timeframe: At 12 weeks

,
Interventionln (ms^2) (Least Squares Mean)
Low-frequencyHigh-frequency
SMT-Enhanced Cardiac Rehabilitation0.170.08
Standard Cardiac Rehabilitation0.280.22

Major Adverse Cardiovascular Events (MACE) - All Cause Death, MI, Cardiac Revascularization and Cardiovascular Hospitalization.

Patients documented all medical encounters on an annual basis after enrollment. Medical records were reviewed, and events, categorized on the basis of American College of Cardiology/American Heart Association criteria. The following medical events were included: all-cause mortality, fatal and nonfatal myocardial infarction (MI), coronary or peripheral artery revascularization, stroke/transient ischemic attack, and unstable angina requiring hospitalization. (NCT00981253)
Timeframe: Baseline through Follow-up (median, 3.2 years)

,
InterventionParticipants (Count of Participants)
All cause mortalityMIStent/CABGStroke/TIAPeripheral RevascularizationAngina Requiring Hospitalization
SMT-enhanced Cardiac Rehabilitation019112
Standard Cardiac Rehabilitation2611132

Trials

1 trial available for nitroglycerin and Anxiety

ArticleYear
Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial.
    BMJ (Clinical research ed.), 1996, Dec-14, Volume: 313, Issue:7071

    Topics: Angina Pectoris; Anxiety; Depression; Follow-Up Studies; Humans; Myocardial Infarction; Nitroglyceri

1996

Other Studies

9 other studies available for nitroglycerin and Anxiety

ArticleYear
Hyperhomocysteinemia Increases Cortical Excitability and Aggravates Mechanical Hyperalgesia and Anxiety in a Nitroglycerine-Induced Migraine Model in Rats.
    Biomolecules, 2022, 05-23, Volume: 12, Issue:5

    Topics: Animals; Anxiety; Cortical Excitability; Female; Homocysteine; Hyperalgesia; Hyperhomocysteinemia; M

2022
Effect of Paeonia lactiflora, a traditional Chinese herb, on migraines based on clinical application and animal behavior analyses.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 118

    Topics: Animals; Anxiety; Behavior, Animal; Calcitonin Gene-Related Peptide; Depression; Drugs, Chinese Herb

2019
Ghrelin attenuates hyperalgesia and light aversion-induced by nitroglycerin in male rats.
    Neuroscience letters, 2016, Sep-06, Volume: 630

    Topics: Animals; Anxiety; Disease Models, Animal; Ghrelin; Hyperalgesia; Male; Migraine Disorders; Nitroglyc

2016
Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
    The European journal of neuroscience, 2017, Volume: 45, Issue:6

    Topics: Animals; Anxiety; Ghrelin; Hydrocortisone; Leukocyte Count; Male; Maze Learning; Migraine Disorders;

2017
INTRACTABLE ANGINA.
    Progress in cardiovascular diseases, 1963, Volume: 6

    Topics: Anemia; Angina Pectoris; Anticoagulants; Anxiety; Cardiac Surgical Procedures; Cardiovascular Diseas

1963
ANGINA PECTORIS--AN EFFECTIVE THERAPEUTIC APPROACH.
    Clinical medicine (Northfield, Ill.), 1963, Volume: 70

    Topics: Angina Pectoris; Anxiety; Anxiety Disorders; Humans; Meprobamate; Nitroglycerin; Pentaerythritol Tet

1963
Coronary heart disease: treating the anxiety component.
    Progress in neuro-psychopharmacology, 1980, Volume: 4, Issue:4-5

    Topics: Angina Pectoris; Anti-Anxiety Agents; Anxiety; Blood Pressure; Clorazepate Dipotassium; Coronary Dis

1980
Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog.
    Archives internationales de pharmacodynamie et de therapie, 1978, Volume: 235, Issue:1

    Topics: Amines; Amiodarone; Angina Pectoris; Animals; Anxiety; Behavior, Animal; Benzylamines; Conditioning,

1978
[Prevention and therapy of angina pectoris and their relationship to dental practice].
    Minerva stomatologica, 1986, Volume: 35, Issue:3

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anxiety; Calcium Channel Blockers; Dental Care; Humans

1986